Long-term oral corticosteroid therapy leads to suppression of the hypothalamo-pituitary-adrenal (HPA) axis (Paris, 1961; Treadwell, Savage, Sever, and Copeman, 1963; Jasani, Boyle, Greig, Dalakos, Browning, Thompson, andBuchanan, 1967). Much work has been done on the influence of the regimen of corticosteroid administration on this suppression. Harter, Reddy, and Thorn (1963) have presented evidence that administration of oral corticosteroid in a single dose given every other day leads to substantially less adrenal suppression than that which occurs with a regimen giving divided doses of corticosteroid over the same period. The doses used in this study were not physiological; that is to say patients received doses of prednisone or prednisolone-equivalent ranging from 20 to 40 mg. daily. Grant, Forsham, and DiRaimondo (1965) have shown that a daily morning dose of 8 mg. Triamcinolone administered to normal subjects over a period of 8 days does not lead to lasting adrenal suppression. Nichols, Nugent, and Tyler (1965) have demonstrated virtually complete suppression of the secretion of cortisol by the adrenal gland for a period of 24 hours following the administration of a physiological dose of corticosteroid (0 5 mg. dexamethasone) given at midnight. The same amount given at 8 a.m. or 4 p.m. caused only temporary suppression of cortisol secretion.
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In the present study we have compared the effect of two regimens of corticosteroid administration on HPA axis suppression as measured by the diurnal rhythm of plasma 1l-OHCS and the plasma 11-OHCS response to f1-24 tetraicosapeptide (Synacthen CIBA), lysine8-vasopressin, and insulininduced hypoglycaemia. The two regimens were: a 4 mg. oral dose of Triamcinolone given at 10 p.m. every day and an 8 mg. oral dose of Triamcinolone given at 8 a.m. every altemate morning. Two groups of patients were treated contemporaneously with one or other of these regimens for a period of exactly one year.
Material and Methods Patients Studied
Twelve patients with "definite" or "classical" rheumatoid arthritis were studied. All had active polyarthritis of at least 6 months' duration, associated with a positive sheep cell agglutination test (SCAT) and radiological evidence of articular erosions in the hands and feet, or both. Definite indication for oral corticosteroid therapy was present in each patient studied: aspirin, phenylbutazone, and indomethacin when given in full doses, singly or in combination, had failed to control the joint symptoms adequately. The patients were admitted to the study consecutively, but divided randomly into two equal groups of six. Their salient clinical and laboratory findings are summarized in Table I (opposite), which shows that they were fairly comparable with respect to duration and severity oftheir joint disease. To one group Triamcinolone was given orally in a dose of 8 0 mg. every 48 hours at 8 a.m., and the other group received Triamcinolone orally in a dose of 4-0 mg. daily given at 10 p.m. (Jasani and others, 1967) . tClassification of Steinbrocker, Traeger, and Batterman (1949 
Diurnal Variation of Plasma ll-OHCS
The diurnal variation of plasma 1 1-OHCS was determined at 8 a.m. and 10 p.m. All patients rested in bed for at least 30 minutes before the venepuncture. At the end of one year's treatment, diurnal variation was determined without stopping Triamcinolone. In this study diurnal rhythm of plasma 11-OHCS has been expressed in the manner described by Perkoff, Eik-Nes, Nugent, Fred, Nimer, Rush, Samuels, and Tyler (1959) .
Synacthen Test
The Synacthen (fl-24 tetraicosapeptide, CIBA) test was carried out, as previously described from this centre (Grieg, Boyle, Jasani, and Maxwell, 1967) , at 9 a.m. with the patients resting in bed having had a light breakfast.
Lysine8-Vasopressin Test
The lysine8-vasopressin test was performed as described by Gwinup (1965) . Basal plasma 11-OHCS was determined at 9 a.m. after a light breakfast. Lysine8-vasopressin in a dose of 10 pressor units was injected intramuscularly (gluteal region). The rise in plasma 1 -OHCS was determined at 60 and 120 minutes after the injection.
Insulin-induced Hypoglycaemia Test
This test was carried out using the standard procedure of Landon, Wynn, and James (1963) . All patients in the present study received 0 -15 u./kg. bodywt. dose of soluble insulin given intravenously. Two basal plasma 11-OHCS levels were determined at an interval of 30 minutes. Further venous blood samples to detect the rise in plasma 1 1-OHCS were taken at 30, 60, 90, and 120 minutes after administration of soluble insulin. Blood sugars were also determined at the same time intervals using a standard ferro ferricyanide method with an Auto-Analyzer (Technicon).
Criteria of Normal Response
The normal range of response (mean ±2 S.D.) for the synacthen and insulin-induced hypoglycaemia tests in our hands have already been reported (Jasani and others, 1967) . Our range of normal response (mean±2 S.D.) to intramuscular administration of lysine8-vasopressin is similar to our range for intravenous lysine8-vasopressin (Jasani and others, 1967) .
Plasma 1 1-OHCS were assayed by the method of Mattingly (1962) . The fluorescence obtained with use of the sulphuric acid-ethanol reagent in this method is largely due to cortisol, but also includes small amounts due to corticosterone (Mattingly, 1962) . Triamcinolone is known not to influence the results of this assay procedure (Mattingly, 1962) to any significant degree.
Results
The results are summarized in Tables II and III. Diurnal Rhythm of Plasma ll-OHCS Table II shows the individual plasma 1 -OHCS levels obtained at 8 a.m. and 10 p.m. in the two groups of patients before administration of Triamcinolone and after one year's therapy.
The mean daily decrement in plasma ll-OHCS before starting steroid therapy was -9,eg./100 ml. (Table II) in the group given Triamcinolone on alternate mornings, and in the group given a daily evening dose of Triamcinolone the mean plasma I1-OHCS decrement was -8-8 [Lg./100 ml. (Table   II ). The corresponding values at the end of one year's therapy were 8 * 9 and -0 * 5 ,ug./100 ml. respectively. This difference between the two groups of patients was not statistically significant before starting steroid therapy, but was highly significant by a Student's "t" test (P<0 *001) at the end of one year's therapy. Using our criteria of normal diurnal variation of plasma 1 1-OHCS (range -3 to -15 ,Ag./100 ml., -9 ,Lg./100 ml.), every patient given a daily evening dose of Triamcinolone exhibited complete loss of diurnal variation of plasma 1 1-OHCS at the end of one year's therapy (Table II) . In contrast, none of the patients receiving 8 mg. Triamcinolone on alternate mornings showed abnormality of plasma 11-OHCS diurnal (using the convention of Perkoff and others, 1959 (Bailey, 1959) to these results, the difference in proportions observed is significant at the 1 per cent. level.
Synacthen Test
The results of plasma 1 -OHCS response to Synacthen before and after therapy for each group of patients are shown in Table III . Before starting steroid therapy there was no significant difference between the mean resting value of plasma 11-OHCS and the mean levels attained 30 minutes after 0 25 mg. Synacthen in the two groups of patients studied.
After one year's therapy, the mean resting plasma 11-OHCS concentration was 10*3 pg./100 ml.
(±S.E. 1 2 ,Lg./100 ml.) in the group of patients given a daily evening dose of Triamcinolone. This value is significantly lower than the corresponding figure of 18-7+1-8 jug./100 ml. observed in this group before steroid therapy. In the group of patients who received Triamcinolone on alternate mornings, no significant difference was observed in the mean plasma I-OHCS level before and after one year's steroid therapy (14 6+2 2 and 17-4+ 1*7 ttg./100 ml. respectively). The response to synacthen stimulation was normal in both groups of patients before and after steroid therapy (Table III) .
Lysine8-Vasopressin Test
Values of plasma 1 1-OHCS observed during the response to lysine8-vasopressin stimulation in the two groups of patients studied are shown in Table  III .
Before administration of Triamcinolone the mean resting plasma 11 -OHCS concentrations were similar in the two groups of patients (Table III) , and the levels obtained at 60 and 120 minutes with 10 pressor units of lysine8-vasopressin administered intramuscularly were virtually identical (Table III) .
At 
Insulin-induced Hypoglycaemia Test
The responses of both groups to insulin hypoglycaemia before therapy are shown in Table III therapy these figures were 14-6+1 0, 14-7+2-0, 15-7+2-2, 29-3+3-0, 33-0+1-9, and 28-5+1-5 -Ug./100 ml. respectively.
After one year's treatment with Triamcinolone two of the six patients who had received the daily evening dose regimen demonstrated a slightly subnormal plasma 11-OHCS response to insulin hypoglycaemia, and the mean plasma 1 1-OHCS values for the group were highly significantly lower at 60, 90, and 120 minutes after insulin (Before steroid therapy the mean plasma 1 1-OHCS values were 16-4+1 5, 15 0+1 7, 18 7±+26, 36-0+2-3, 39 * 7 + I * 6, and 33 * 4 + 3 * 9 ,Ag./100 ml.; after steroid therapy the corresponding values were: 12*2 + 13, 10-3+15, 12-9+2-6, 22-2+1-3, 22-7+1-6, and 18 *2 +1 * 5 izg./100 ml. respectively).
These data suggest that patients who received the daily evening regimen of steroid administration have a more subnormal response to insulin hypoglycaemia compared with patients who were treated with the regimen of steroid administration on alternate mornings. This suggestion is strengthened by the observation that the mean 1 1-OHCS response to insulin was significantly lower at 90 and 120 minutes in the patients receiving the evening schedule compared with patients receiving the alternate morning schedule (Table III) .
Discussion
This study was designed to assess the influence of two different regimens of administration of oral corticosteroid drugs on HPA axis suppression. The reasons for selection of these regimens were as follows:
(1) Harter and others (1962) suggested alternate daily single-dose corticosteroid therapy on the grounds that less adrenal suppression was thereby produced than with multiple daily doses.
(2) Nichols and others (1965) showed that a small single dose of dexamethasone given at midnight resulted in virtually complete suppression of plasma 17-OHCS levels and of cortisol secretion by the adrenal gland for 24 hours, resulting in loss of diurnal variation in plasma cortisol; they suggested that it might be possible to avoid adrenal suppression by omitting the nightly dose of corticosteroid.
However, some workers (De Andrade, McCormick, and Hill, 1964) have shown that the small nightly dose of corticosteroid results in more adequate symptom relief in some patients with rheumatoid arthritis. It seemed important to determine the relative HPA axis suppressive effects of these regimens on a long-term basis.
The results show that patients given a daily evening dose of Triamcinolone developed complete loss of diurnal rhythm of plasma 1 1-OHCS and this observation is in accord with the findings of Nichols and others (1965) . When patients were treated with 8 mg. Triamcinolone on alternate mornings, however, no abnormality of diurnal rhythm was apparent even after one year of treatment. This observation suggests that the integrity of diurnal rhythm during this regimen of steroid administration may remain permanently unaltered. This finding does not necessarily imply long-term integrity of the HPA axis.
At the end of one year's therapy both groups of patients had responses to insulin-induced hypoglycaemia which were significantly poorer compared with their responses before therapy. This observation suggests that HPA axis suppression may be induced by both of these regimens of corticosteroid administration on a long-term basis. Admittedly the degree of suppression observed in the present study was slight because the responses of both groups of patients to Synacthen and to lysine8-vasopressin were normal. However, one might expect that longer administration of corticosteroid, perhaps in higher dosage, might produce more marked suppression of the axis resulting in abnormalities of the plasma 1l-OHCS responses to Synacthen and to lysine8-vasopressin.
Significantly greater impairment of the plasma 1 1-OHCS response to insulin hypoglycaemia stimulation was present in the group of patients given a single daily evening dose of corticosteroid.
The finding of low morning plasma 1l-OHCS levels in the group of patients given daily evening Triamcinolone therapy reflects the suppression of cortisol production for 24 hours which was described by Nichols and others (1965) after a physiological dose of steroid given at midnight. From the practical point of view the adrenal glands of these patients can still respond to Synacthen stimulation and they are able to respond to lysine8-vasopressin stimulation in spite of the fact that they have presumably had reduction of ACTH release from the pituitary gland and of cortisol from the adrenal glands for one year. Nonetheless, these patients do show more significant suppression of the HPA axis as judged by their capacity to elevate plasma 11-OHCS levels in response to insulininduced hypoglycaemia than do the patients given the regimen of 48-hour single-dose treatment advocated by Harter and others (1965) . It would appear that the latter regimen causes less HPA axis suppression when corticosteroid drugs are given in PHYSIOLOGICAL amounts, and this finding parallels the observation of Harter and others (1965) that less adrenal suppression results from this regimen when corticosteroids are given in PHARMACOLOGICAL amounts.
Data has previously been presented in a retrospective study which suggests that an impaired plasma 11-OHCS response to insulin-induced hypoglycaemia is likely to be the first abnormality to develop in corticosteroid-induced HPA axis suppression (Jasani and others, 1967) . The present prospective study confirms this suggestion.
A consideration of the clinical progress of both groups of patients is appropriate: to show that less significant suppression of the HPA axis occurs with one regimen of therapy is of little value unless it can be demonstrated that the symptomatic benefit achieved by this regimen is equipotent with other schemes of corticosteroid dosage. As can be seen from Table IV , there was a comparable fall in the articular index in both groups of patients after one year of corticosteroid therapy. This objective evaluation of analgesic response was not, however, confirmed by symptom inquiry. The patients Summary A prospective study of the degree of suppression of the hypothalamo-pituitary-adrenal (HPA) axis after two regimens of oral corticosteroid therapy has been undertaken in twelve patients with rheumatoid arthritis. Diurnal rhythm of plasma 11-OHCS and the plasma 1 -OHCS response to synacthen, lysine8-vasopressin, and insulin hypoglycaemia stimulation was studied before and after one year's treatment with Triamcinolone. Six patients received a single daily evening dose of 4 mg.; six patients were given a single dose of 8 mg. on alternate mornings.
Slight but significant HPA axis suppression was seen with both regimens of steroid administration, as manifested by diminished plasma 1 -OHCS responses to insulin induced hypoglycaemia. This response was significantly more impaired in the patients who had received Triamcinolone in a single evening dose than in those who had received the corticosteroid on alternate mornings. Diurnal rhythm was unaltered in the latter patients after one year's treatment with Triamcinolone but was uniformly abolished in the former patients. The data confirm in a prospective fashion the suggestion that the plasma 1 1-OHCS response to insulin hypoglycaemia is the first to become impaired during long-term corticosteroid therapy.
Neither group of patients derived total symptom relief from either regimen of therapy. More observations are required to assess fully the clinical value of alternate morning therapy. Una inhibicion ligera pero significativa del eje HPA se observ6 con ambos regimenes steroideos, manifestandose por respuestas debiles de los 11-hidroxicorticosteroides a la hipoglicemia insulinica. Esta respesta fue significativamente mas floja en los que recibian la dosis vesperal que en los que recibian la triamcinolona por la maniana cada dos dias. Despues de un ailo de tratamiento el ritmo diumo fue sin cambiar en los ultimos, pero se vio uniformemente abolido en los primeros, Estos resultados confirman la hip6tesis de que la respuesta de los 1-hidroxicorticosteroides plasmaticos a la hipoglicemia insulinica se debilita primera en el curso de una terapia corticosteroidea sostenida.
En ninguno de los grupos los enfermos beneficiaron de un alivio completo. Se necesita mas tiempo de observaci6n para apreciar las ventajas clinicas del tratamiento cada dos dias. 
